首页> 美国政府科技报告 >Risk Assessment on (2,4,5-Trichlorophenoxy) Acetic Acid (2,4,5-T), (2,4,5-Trichlorophenoxy) Propionic Acid, 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD)
【24h】

Risk Assessment on (2,4,5-Trichlorophenoxy) Acetic Acid (2,4,5-T), (2,4,5-Trichlorophenoxy) Propionic Acid, 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD)

机译:(2,4,5-三氯苯氧基)乙酸(2,4,5-T),(2,4,5-三氯苯氧基)丙酸,2,3,7,8-四氯二苯并-p-二恶英的风险评估( TCDD)

获取原文

摘要

Carcinogenic responses have been induced in mice and rats at low doses of TCDD. TCDD has been shown to be a cancer promoter. These results, together with the strongly suggestive evidence in epidemiology studies, constitute substantial evidence that TCDD is likely to be a human carcinogen. It appears that TCDD is a more potent carcinogen than aflatoxin B1 which is one of the most potent carcinogens known. The levels of TCDD (contained as an unavoidable contaminant of the 2,4,5-T) used in the 2,4,5-T studies apparently were too small to produce an observable response in those experiments. The lack of a statistically significant tumor incidence in most of the studies on the 2,4,5-T product may be attributed to the very low levels of TCDD in the product relative to the levels at which it produced carcinogenic effects in rats and mice, as well as to deficiencies of those studies. However, since TCDD is a carcinogen, any product containing TCDD, including 2,4,5-T and silvix, can be considered to pose a human carcinogenic hazard. Furthermore, a rat study on specially purified 2,4,5-T provides highly suggestive evidence that essentially pure 2,4,5-T may be a human carcinogen. Quantitative assessments have been calculated for the carcinogenic risk posed to humans.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号